Related Experiment Video
Updated: Jan 26, 2026
Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential
Thomas R O'Brien1, Howard A Young2, Raymond P Donnelly3
1Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Insights
The first interferon lambda (IFN-λ) meeting highlighted its disease impact and translational potential. Scientists discussed IFN-λ biology, genetics, and roles in infections like Hepatitis C, and in liver disease.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Interferon lambda (IFN-λ) is a critical cytokine in innate immunity.
- Limited understanding of IFN-λ's broad biological roles and therapeutic potential.
- Need for interdisciplinary communication in IFN-λ research.
Purpose of the Study:
- To convene the first international meeting exclusively on interferon lambda.
- To foster communication and collaboration among diverse scientific disciplines.
- To explore the disease impact and translational potential of IFN-λ.
Main Methods:
- The meeting focused on invited talks and discussions.
- Sessions covered IFN-λ biology, genetics, therapy, and specific disease contexts.
- International experts from various fields presented their research.
Main Results:
- The meeting successfully brought together experts in interferon lambda research.
- Key areas of discussion included IFN-λ's role in viral infections (e.g., Hepatitis C), other infections, and hepatic fibrosis/cancer.
- Established the foundation for future IFN-λ research and collaborations.
Conclusions:
- Interferon lambda (IFN-λ) holds significant, yet underexplored, potential in disease treatment and prevention.
- Enhanced interdisciplinary collaboration is crucial for advancing IFN-λ research.
- Future meetings are planned to continue this scientific dialogue.
Abstract:
A meeting entitled, "Interferon Lambda: Disease Impact and Translational Potential," was held on the campus of the National Institutes of Health in Bethesda, Maryland, on October 25-26, 2018. To our knowledge, this was the first meeting that focused exclusively on interferon lambda (IFN-λ). The meeting's purpose was to enhance interdisciplinary communication and promote new collaborations. The gathering brought together an international group of scientists from a wide range of disciplines. Sessions included: IFN-λ Biology, Therapy and Genetic Variation; IFN-λ and Hepatitis C Virus Infection; IFN-λ in Other Infections; and IFN-λ-Hepatic Fibrosis and Cancer. The next meeting on IFN-λ is planned for 2020.
Related Concept Videos
01:16Therapeutic Drug Monitoring: Overview and Classification
01:15Parkinson's Disease: Overview
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:19Impact of Groups on Groups
01:30Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...